• Register
  • Login

Iraqi Postgraduate Medical Journal

  1. Home
  2. Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

Copyrights and Licensing

Home

About Journal

Aim and Scope

Editorial Board

Peer Review Process

Copyrights and Licensing

Indexing and Abstracting

Plagiarism Policy

Author's Guide

Article processing charge (APC)

Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata

    Authors

    • Husam Ali Salman 1
    • Aliaa Samir Hameed 2

    1 College of Medicine/ Baghdad University/ Dermatology and Venereology Department.

    2 Center of Dermatology / Medical City Hospital, Baghdad, Iraq

,

Document Type : Research Paper

10.52573/ipmj.2023.180585
  • Article Information
  • References
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

ABSTRACT:
BACKGROUND:
Alopecia areata is an inflammatory, non-scaring type of hair loss. Microneedling is a new therapeutic procedure used in dermatology. It facilitates the absorption of topical therapies across the epidermis.
AIM OF STUDY:
Evaluating the efficacy of Microneedling combined with clobetasol propionate 0.05% cream versus clobetasol propionate 0.05% cream alone in treatment of alopecia areata.
PATIENTS AND METHODS:
This study was carried out on 20 patients and the total number of patches was 99. In the same patient,              at least 2 patches were selected to be treated as group A or B; so, the 99 patches were divided in to two groups.
Group A: Microneedling combined with clobetasol propionate 0.05% cream: 51 patches (from 20 patients) were treated using a dermapen devise. The cream was applied before and after microneedling and a total of four sessions were done at 2 weeks interval, then patients were seen after 2 weeks from              the last session for follow up. Group B: clobetasol propionate 0.05% cream alone: 48 patches (from               the same 20 patients) were treated, the cream was applied twice daily with gentle massage for 3-5 minutes for 8 weeks duration. Patients were seen at 2 weeks interval.
RESULTS:
At 8th week visit: the response to treatment in group A was seen in 58.8% of the patches and 63.3% of them showed complete coarse hair regrowth while in group B, the response to treatment was seen in 58.3% of the patches and 32.1% of them showed complete coarse hair regrowth. When two groups were compared regarding complete hair regrowth there was statistically significant difference.
CONCLUSION:
Combination of Microneedling with clobetasol propionate 0.05% cream is a promising, safe and easy to perform technique in the treatment of alopecia areata
 
 

Keywords

  • Alopecia areata
  • Microneedling
  • clobetasol propionate
  • XML
  • PDF 176.8 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
References
  1. REFERENCE:

    1. Strazzulla LC, Wang EH, Avila L, et al. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. Journal of the American Academy of Dermatology. 2018 Jan 1; 78:1-2.
    2. Kranseler JS, Sidbury R. Alopecia areata: Update on management. Indian Journal of Paediatric Dermatology. 2017; 18:261-66.
    3. Kassim J.M, Shipman A.R, Szczecinska W,et al. How effective is intralesional injection of triamcinolone acetonide compared with topical treatments in inducing and maintaining hair growth in patients with alopecia areata? A Critically Appraised Topic. British Journal of Dermatology. 2014; 170:766-71.
    4. Sperling LC, Sinclair RD and El Shabrawi-Caelen L. Alopecias. In: Bolognia JL, Schaffer JV and Cerroni L. Dermatology. Fourth edition. Elsevier China; 2018:1162-85.
    5. Finner AM. Alopecia areata: Clinical presentation, diagnosis, and unusual cases. Dermatologic Therapy 2011;24:348-54.
    6. Messenger AG, Sinclair2 RD, Farrant P, et al. Acquired Disorders of Hair. In: Griffiths CEM, Barker J, Bleiker T, et al. Rook’s Textbook of Dermatology. Ninth Edition. V 3. Wiley-Blackwell New Delhi; 2016:89.1-89.77
    7. Iriarte c, Awosika O, Rengifo-Pardo M, et al. Review of applications of microneedling in dermatology. Clinical, Cosmetic and Investigational Dermatology 2017;10:289–98.
    8. Hou A, Cohen B, Haimovic A, et al. Microneedling: A Comprehensive Review. Dermatologic Surgery 2017;43:321–39.
    9. Sharquie KE, Noaimi AA and Hafedh Z. Intralesional Therapy of Alopecia Areata by 1% Lactic Acid Solution versus Triamcinolone Acetoind Injection (Interventional, Case Controlled, Single Blinded, Comparative Study). Journal of Dental and Medical Sciences 2015;4:39-45.
    10. Alsantali A. Alopecia areata: a new treatment plan. Clinical, Cosmetic and Investigational Dermatology 2011;4:107–15.

     

    1. Fertig RM, GamretAC, CervantesJ et al. Microneedling for the treatment of hair loss?.Journal of Eurepian academy of dermatology and venerilogy 2018; 32:564-69.
    2. Chandrashekar B, Yepuri V, Mysore V. Alopecia areata-successful outcome with microneedling and triamcinolone acetonide. Journal of Cutaneous Aesthetic Surgery 2014;7:63-64.
    3. Beergouder SL and Reshme A. Scalp micro-needling: A new tool in the treatment of alopecia totalis. Journal of Indian Association of Dermatologist, Venereologist and Leprologists (IADVL) Karnataka Branch 2020;4;164-66.
    4. Asad U, Wallis D & Tarbox M. Ophiasis alopecia areata treated with microneedling. Baylor University Medical Center Proceedings 2020;33:413-14.
    5. Dhurat R, Sukesh MS, Avhad G, et al. A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study. International Journal of Trichology 2013; 5: 6–11.
    6. Dhurat R and Mathapati S. Response to Microneedling Treatment in Men with Androgenetic Alopecia Who Failed to Respond to Conventional Therapy. Indian Journal of Dermatology 2015; 60:260-63.
    7. Molinelli E, Campanati A, Brisigotti V, et al. Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study.

     

    • Article View: 277
    • PDF Download: 270
Iraqi Postgraduate Medical Journal
Volume 22, Issue 2
April 2023
Page 166-171
Files
  • XML
  • PDF 176.8 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 277
  • PDF Download: 270

APA

Salman, H., & Hameed, A. (2023). Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata. Iraqi Postgraduate Medical Journal, 22(2), 166-171. doi: 10.52573/ipmj.2023.180585

MLA

Husam Ali Salman; Aliaa Samir Hameed. "Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata". Iraqi Postgraduate Medical Journal, 22, 2, 2023, 166-171. doi: 10.52573/ipmj.2023.180585

HARVARD

Salman, H., Hameed, A. (2023). 'Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata', Iraqi Postgraduate Medical Journal, 22(2), pp. 166-171. doi: 10.52573/ipmj.2023.180585

VANCOUVER

Salman, H., Hameed, A. Microneedling Plus Clobetasol Propionate 0.05% Cream versus Clobetasol Propionate 0.05% Cream Alone in the Treatment of Alopecia Areata. Iraqi Postgraduate Medical Journal, 2023; 22(2): 166-171. doi: 10.52573/ipmj.2023.180585

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

This work is licensed under          CC BY 4.0    

 

 

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by iJournalPro.com